| Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ... NPJ precision oncology 4 (1), 24, 2020 | 113 | 2020 |
| Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics A Sorolla, E Wang, E Golden, C Duffy, ST Henriques, AD Redfern, ... Oncogene 39 (6), 1167-1184, 2020 | 81 | 2020 |
| Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers E Wang, A Sorolla, PT Cunningham, HM Bogdawa, S Beck, E Golden, ... Oncogene 38 (1), 140-150, 2019 | 68 | 2019 |
| From seabed to bedside: A review on promising marine anticancer compounds E Wang, MA Sorolla, PD Gopal Krishnan, A Sorolla Biomolecules 10 (2), 248, 2020 | 45 | 2020 |
| Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers JA Kretzmann, CW Evans, C Moses, A Sorolla, AL Kretzmann, E Wang, ... Chemical Science 10 (33), 7718-7727, 2019 | 41 | 2019 |
| Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides A Sorolla, E Wang, TD Clemons, CW Evans, JHC Plani-Lam, E Golden, ... Nanomedicine: Nanotechnology, Biology and Medicine 20, 102003, 2019 | 39 | 2019 |
| Peptides, proteins and nanotechnology: A promising synergy for breast cancer targeting and treatment A Sorolla, MA Sorolla, E Wang, V Ceña Expert Opinion on Drug Delivery 17 (11), 1597-1613, 2020 | 29 | 2020 |
| Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide A Sorolla, D Ho, E Wang, CW Evans, CFG Ormonde, R Rashwan, ... Nanoscale 8 (17), 9343-9353, 2016 | 27 | 2016 |
| The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer E Golden, R Rashwan, EA Woodward, A Sgro, E Wang, A Sorolla, ... Nature Communications 12 (1), 1920, 2021 | 23 | 2021 |
| Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. NPJ Precis Oncol 4: 24 C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ... | 11 | 2020 |
| Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer C Waryah, J Cursons, M Foroutan, C Pflueger, E Wang, R Molania, ... Advanced Science 10 (22), 2301802, 2023 | 10 | 2023 |
| Sensitizing endometrial cancer to ionizing radiation by multi-tyrosine kinase inhibition E Wang, A Sorolla Journal of Gynecologic Oncology 31 (3), 2020 | 7 | 2020 |
| Design and characterization of a cell-penetrating peptide derived from the SOX2 transcription factor NS Gandhi, E Wang, A Sorolla, YJ Kan, A Malik, J Batra, KA Young, ... International Journal of Molecular Sciences 22 (17), 9354, 2021 | 5 | 2021 |
| Three-dimensional (3D) structure prediction of the American and African oil-palms β-ketoacyl-[ACP] synthase-II protein by comparative modelling E Wang, S Chinni, SJ Bhore Bioinformation 10 (3), 130, 2014 | 5 | 2014 |
| Topical negative pressure therapy and compression in the management of venous leg ulcers: a pilot study E Wang, R Tang, N Walsh, L Stopher, C Bharat, S Ponosh, S Jansen Wound Practice & Research: Journal of the Australian Wound Management …, 2017 | 4 | 2017 |
| Nanoparticles for Neural Applications JG Ovejero, E Wang, S Veintemillas-Verdaguer, MP Morales, A Sorolla Engineering Biomaterials for Neural Applications: Targeting Traumatic Brain …, 2021 | 3 | 2021 |
| Computational analysis of common bean (Phaseolus vulgaris L., genotype BAT93) lycopene β-cyclase and β-carotene hydroxylase gene's cDNA SJ Bhore, K Amelia, E Wang, S Priyadharsini, FH Shah Bioinformation 9 (4), 197, 2013 | 2 | 2013 |
| Multifunctional polymer nanoparticles: Combinatorial therapy for triple negative breast cancers C Evans, A Sorolla, D Ho, E Wang, C Ormonde, R Rashwan, S Iyer, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016 | 1 | 2016 |
| Novel targeted therapeutic strategies in the treatment of triple-negative breast cancer E Wang | | 2019 |
| Development of a polymeric agent for the in vivo delivery of CRISPR system to activate tumour suppressor genes J Kretzmann, C Evans, C Moses, AS Bardaji, A Kretzmann, E Wang, D Ho, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 254, 2017 | | 2017 |
